Full Press Release Details
INDIANAPOLIS , Feb. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will participate in the Guggenheim Oncology Conference on Thursday, Feb. 9 , 2023. Jacob Van Naarden, executive vice president and CEO, Loxo@Lilly and David Hyman , M.D., chief medical officer, Loxo@Lilly, will participate in a fireside chat at 10:10 a.m., Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 30 days.
| Refer to: | Jordan Bishop; [email protected] ; 317-473-5712 (Media) |
| Joe Fletcher; [email protected] ; 317-296-2884 (Investors) |
SOURCE Eli Lilly and Company